Hillrom
Medtronic-Covidien: What does it mean for medtech? | The week in medtech M&A
Hill-Rom to pay $250M for German OR infrastructure maker
Hill-Rom Holdings (NYSE:HRC) said today that it agreed to put up $250 million in cash for the operating room infrastructure arm of Germany’s Trumpf Group.
Hill-Rom lays of 350 to save $30M amid rough outlook
Hill-Rom Holdings (NYSE:HRC) announced today that it will cut about 350 employees in efforts to save about $30 million annually as the device maker looks forward to a potentially tough year.
Cambridge Heart chairman, ex-CEO both resign | Personnel Moves
Cambridge Heart (NSDQ:CAMH) said chairman and interim president Roderick de Greef and former president & CEO Ali Haghighi-Mood have both resigned from the medical device company.
Hill-Rom rises on Q3 prelims, needs new CFO
Hill-Rom wins 510(k) clearance for its MetaNeb airway clearing system
Hill-Rom Holdings (NYSE:HRC) landed 510(k) clearance from the FDA for its MetaNeb 4.0 airway clearing system, which combines airway oscillation and pressure to expand weak lungs and encourage normal mucus growth.
NxStage Medical taps Funari to replace Chambon as chairman | Personnel Moves
NxStage Medical (NSDQ:NXTM) named Robert Funari to replace Philippe Chambon as non-executive chairman after 15 years on the medical device company’s board of directors.
Hospira plays musical chairs | Personnel Moves
Medical devices companies in 2012: The year of the layoff
The medical device industry had a lot of big stories during the last year, including tales of recalls, lawsuits and CEO swapping, but the single factor that drove more big headlines than any other was news of layoffs.
Some of the biggest companies in the industry announced significant cuts in 2012, amounting to about 7,000 reported layoffs, by some estimates.